Alexa Fluor® 555 Anti-SMYD3 antibody [EPR11107(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal SMYD3 antibody - conjugated to Alexa Fluor® 555.
View Alternative Names
ZMYND1, ZNFN3A1, SMYD3, Histone-lysine N-methyltransferase SMYD3, SET and MYND domain-containing protein 3, Zinc finger MYND domain-containing protein 1
Related conjugates and formulations (10)
-
Anti-SMYD3 antibody [EPR11107(2)]
-
578 PE
PE Anti-SMYD3 antibody [EPR11107(2)]
-
660 APC
APC Anti-SMYD3 antibody [EPR11107(2)]
-
HRP Anti-SMYD3 antibody [EPR11107(2)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-SMYD3 antibody [EPR11107(2)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-SMYD3 antibody [EPR11107(2)]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-SMYD3 antibody [EPR11107(2)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-SMYD3 antibody [EPR11107(2)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SMYD3 antibody [EPR11107(2)]
-
Anti-SMYD3 antibody [EPR11107(2)] - BSA and Azide free
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This methyltransferase regulates transcriptional activation by methylating histones. It acts as part of transcriptional coactivator complexes interacting with RNA polymerase II. SMYD3 modulates the expression of genes involved in cell proliferation and cancer progression. Additionally it interacts with proteins like Heat Shock Protein 90 (HSP90) and promotes the stabilization of substrate proteins. Its influence extends to non-histone proteins which suggests a wider impact on cellular signaling and structure.
Pathways
SMYD3 is involved in the MAPK (Mitogen-Activated Protein Kinase) signaling pathway an important regulator of cell differentiation proliferation and survival. It interacts with key proteins in this pathway such as ERK2 (Extracellular signal-regulated kinase 2) influencing cellular outcomes. SMYD3 also plays a role in the Wnt signaling pathway which is important for development and oncogenesis. This interaction with signaling pathways underlines its significant regulatory functions within the cell.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Associated Products
Alternative Version
Primary Antibodies
AB232626
Anti-SMYD3 antibody [EPR11107(2)] - BSA and Azide free
primary-antibodies
smyd3-antibody-epr111072-bsa-and-azide-free-ab232626
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com